Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin can increase cashmere yield by altering gene expression and restarting the growth cycle early.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Stem cells could improve hair growth and new treatments for baldness are being researched.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

The conclusion is that tissue structure is key for stem cell communication and maintaining healthy tissues.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Chilled ATPv-supplemented saline best preserves hair grafts' key genes.

CD2 might be a new treatment target for patchy alopecia areata.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

No cure exists for alopecia areata, and treatments are personalized.

NF-κB is crucial for zebrafish heart repair, affecting heart cell growth and repair processes.

Non-coding RNAs play key roles in the hair growth cycle of Angora rabbits.

Understanding glycans and enzymes that alter them is key to controlling hair growth.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Fully regenerating human hair follicles not yet achieved.

Hair follicles in the back of the rosette fancy mouse have reversed orientations due to a gene mutation.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Chronic stress in mice changes skin metabolism and gene expression, leading to hair loss.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.